Short Interest in OKYO Pharma Limited (NASDAQ:OKYO) Decreases By 35.5%

OKYO Pharma Limited (NASDAQ:OKYO) was the recipient of a large decrease in short interest in March. As of March 15th, there was short interest totalling 217,900 shares, a decrease of 35.5% from the February 28th total of 338,000 shares. Currently, 0.9% of the company’s shares are sold short. Based on an average daily trading volume, of 178,700 shares, the short-interest ratio is presently 1.2 days.

OKYO Pharma Price Performance

Shares of NASDAQ OKYO traded down $0.08 during trading on Monday, hitting $1.27. 81,489 shares of the company traded hands, compared to its average volume of 192,400. The business’s fifty day moving average is $1.21 and its 200 day moving average is $1.12. OKYO Pharma has a fifty-two week low of $0.81 and a fifty-two week high of $1.74.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 price objective on shares of OKYO Pharma in a research note on Tuesday, February 18th.

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.